Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F18%3A10381191" target="_blank" >RIV/00216208:11150/18:10381191 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00179906:_____/18:10381191

Výsledek na webu

<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.1165" target="_blank" >https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.1165</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/ejhf.1165" target="_blank" >10.1002/ejhf.1165</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge

Popis výsledku v původním jazyce

Cancer and heart failure (HF) are common medical conditions with a steadily rising prevalence in industrialized countries, particularly in the elderly, and they both potentially carry a poor prognosis. A new diagnosis of malignancy in subjects with pre-existing HF is not infrequent, and challenges HF specialists as well as oncologists with complex questions relating to both HF and cancer management. An increased incidence of cancer in patients with established HF has also been suggested. This review paper summarizes the epidemiology and the prognostic implications of cancer occurrence in HF, the impact of pre-existing HF on cancer treatment decisions and the impact of cancer on HF therapeutic options, while providing some practical suggestions regarding patient care and highlighting gaps in knowledge.

Název v anglickém jazyce

Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge

Popis výsledku anglicky

Cancer and heart failure (HF) are common medical conditions with a steadily rising prevalence in industrialized countries, particularly in the elderly, and they both potentially carry a poor prognosis. A new diagnosis of malignancy in subjects with pre-existing HF is not infrequent, and challenges HF specialists as well as oncologists with complex questions relating to both HF and cancer management. An increased incidence of cancer in patients with established HF has also been suggested. This review paper summarizes the epidemiology and the prognostic implications of cancer occurrence in HF, the impact of pre-existing HF on cancer treatment decisions and the impact of cancer on HF therapeutic options, while providing some practical suggestions regarding patient care and highlighting gaps in knowledge.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Journal of Heart Failure

ISSN

1388-9842

e-ISSN

—

Svazek periodika

20

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

9

Strana od-do

879-887

Kód UT WoS článku

000431633400009

EID výsledku v databázi Scopus

2-s2.0-85042190257